BACKGROUND: Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an important strategy for im…
BACKGROUND: Additional treatment with a gonadotropin-releasing hormone (GnRH) agonist (GnRHa) before IVF-ET (ultralong GnRHa therapy) has been reported to improve the outcome of IVF-ET in endometriosis patients. However, the mechanism of ul…
Additional treatment with a gonadotropin-releasing hormone (GnRH) agonist (GnRHa) before IVF-ET (ultralong GnRHa therapy) has been reported to improve the outcome of IVF-ET in endometriosis patients. However, the mechanism of ultralong GnRH…
ObjectiveTo examine whether thin endometria can be improved by increasing uterine radial artery (uRA) blood flow.DesignA prospective observational study.SettingUniversity hospital and city general hospital.Patient(s)Sixty-one patients with …
ObjectiveTo characterize pathophysiologic features of a "thin" endometrium.DesignA prospective observational study.SettingUniversity Hospital and City General Hospital.Patient(s)Patients with normal-thickness endometrium (Normal-Em group: e…